Transparency Market Research Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Single User License:
USD 4595 Multi User License:
USD 7595 Corporate User License:
USD 10595
Published Date
103 Page Report
28-May-2014
Buy Now
Request Sample
Press Release Medical Imaging Reagents Market Expected to Reach USD 18.5 Billion Globally in 2019: Transparency Market Research
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Medical Imaging Reagents Market
REPORT DESCRIPTION
According to a new market report published by Transparency Market Research "Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global medical imaging reagents market was valued at USD 10.3 billion in 2012 and is expected to grow at a CAGR of 8.8% from 2013 to 2019, to reach an estimated value of USD 18.5 billion in 2019. Browse the full Medical Imaging Reagents Market Report at http://www.transparencymarketresearch.com/biologic-imaging-reagents-market.html Medical imaging reagents are chemical compounds specially designed to enhance images produced through imaging systems. Medical imaging reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. The development of a medical imaging reagent involves synthesizing it to target a particular biological process, after which imaging systems are adjusted to neutralize the particular target. Medical imaging reagents are first studied via pre-clinical animal research before engaging in human clinical studies. The growth of the medical imaging reagents market can be attributed to the increasing demand for diagnostic and functional imaging technologies. In addition, companies in this industry are trying to stay abreast with technological innovations such as hybrid imaging modalities (e.g. SPECT + MR and PET + CT), which would alternatively boost the market growth of novel imaging reagents such as nuclear reagents and antiparticles. Get Free Sample Reports at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2263 According to the Union for International Cancer Control (UICC), worldwide cancer cases are estimated to rise by almost 75% and reach approximately 25 million over the next two decades. Moreover, according to the American Cancer Society, it has been estimated that in 2014, approximately 1,665,540 new cases of cancer would be diagnosed and almost 585,720 deaths would occur due to cancer in the U.S. This increasing base of cancer patients would need advanced diagnostic imaging modalities such as photoacoustic imaging and PET+MRI as well as imaging reagents for better diagnosis, prevention and treatment of the disease, which would consequently increase the demand for medical imaging reagents.
Transparency Market Research
2
Defibrillators Market
The medical imaging reagents market has been primarily segmented by class, by technology and by applications. The medical imaging reagents class market further comprises contrast reagents, optical reagents and nuclear reagents. The contrast reagents market of the medical imaging reagents accounted for the largest market. However, among these categories, the nuclear reagents market is expected to foresee highest growth rate of over 14% from 2013 to 2019. Moreover, medical imaging reagents technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. The radiopharmaceuticals technology market of the medical imaging reagents accounted for the largest market due to the increased awareness about radioisotopes and high patient preference. Nevertheless, among these imaging reagent technologies, nanoparticles technology is anticipated to grow at the fastest growth rate of 9.1% from 2013 to 2019. Furthermore, medical imaging reagents application segment consists of diagnostics, drug discovery and development as well as research and development. Browse Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html Among the various application areas medical imaging reagents, drug discovery and development is expected to witness the fastest growth during the forecast period owing to the growing adoption rate of medical imaging reagents in the development of nuclear medicines and medical interventions. However, diagnostics applications accounted for the largest market in terms of revenue due to the escalating patient base of cancer and cardiovascular diseases. It is expected that by the year 2019, the market value of imaging reagents for diagnostic purposes shall be worth more than USD 10 billion. Geographically North America accounted for the largest market in the year 2012 (over 40%) followed by Europe. However, Asia Pacific is estimated to demonstrate the fastest growth rate owing to the expected rise in chronic diseases such as cancer and cardiovascular diseases coupled with rise in disposable income and growing awareness. This market is highly consolidated in nature characterized by top five players occupying approximately 80% of the overall market share. The major players of this market include Bayer Healthcare AG, Becton Dickinson & Company, Bracco Imaging SpA, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals and Thermo Fisher Scientific, Inc.
Transparency Market Research
3
Defibrillators Market
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.3.2 Assumptions
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Medical Imaging Reagents Market
Chapter 3 Market Overview 3.1 Introduction and Market Definition 3.2 Market Dynamics 3.2.1 Market Drivers 3.2.1.1 Growing number of elderly population expected to drive market growth 3.2.1.2 Increasing prevalence rate of cancer, cardiovascular and neurological diseases expected to trigger market growth 3.2.1.3 Escalating demand for diagnostic imaging procedures influences imaging reagents sales 3.2.1.4 Technological development likely to spur the growth of the imaging reagents market 3.2.2 Market Restraints
Transparency Market Research
4
Defibrillators Market
3.2.2.1 Shortage of supplies of imaging reagents impede the growth of the market 3.2.2.2 Stringent regulatory approvals likely to hamper the market growth 3.2.2.3 Reluctance in adopting nuclear products restrict the market growth
Browse the full Medical Imaging Reagents Market Report at http://www.transparencymarketresearch.com/biologic-imaging-reagents-market.html
3.2.3 Market Opportunities 3.2.3.1 Strengthening distribution network in emerging markets 3.2.3.2 Development of nuclear products based personalized therapy 3.3 Porter’s Five Forces Analysis 3.3.1 Bargaining Power of Suppliers 3.3.2 Bargaining Power of Buyers 3.3.3 Threat of New Entrants 3.3.4 Threat of Substitutes 3.3.5 Competitive Rivalry 3.4 Market Attractiveness Analysis: Global Medical Imaging Reagents Market, by Geography 3.5 Market Share Analysis for Global Medical Imaging Reagents, by Key Players, 2012 (Value %)
Chapter 4 Global Medical Imaging Reagents Market, by Class 4.1 Overview 4.1.1 Global Medical Imaging Reagents Market Revenue, by Class, 2011 – 2019 (USD Million)
Transparency Market Research
5
Defibrillators Market
4.2 Contrast Reagents 4.2.1 Global Contrast Reagents Market Revenue, 2011 – 2019 (USD Million) 4.3 Optical Reagents 4.3.1 Global Optical Reagents Market Revenue, 2011 – 2019 (USD Million) 4.4 Nuclear Reagents 4.4.1 Global Nuclear Reagents Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Global Medical Imaging Reagents Market, by Technology 5.1 Overview 5.1.1 Global Medical Imaging Reagents Market Revenue, by Technology, 2011 – 2019 (USD Million) 5.2 Nanoparticles 5.2.1 Global Nanoparticles Market Revenue, 2011 – 2019 (USD Million) 5.3 Fluorescent Proteins 5.3.1 Global Fluorescent Proteins Market Revenue, 2011 – 2019 (USD Million) 5.4 Fluorescent Dyes and Probes 5.4.1 Global Fluorescent Dyes and Probes Market Revenue, 2011 – 2019 (USD Million) 5.5 Radiopharmaceuticals 5.5.1 Global Radiopharmaceuticals Market Revenue, 2011 – 2019 (USD Million) 5.6 Quantum Dots 5.6.1 Global Quantum Dots Market Revenue, 2011 – 2019 (USD Million)
Browse the full Medical Imaging Reagents Market Report at http://www.transparencymarketresearch.com/biologic-imaging-reagents-market.html
Transparency Market Research
6
Defibrillators Market
Chapter 6 Global Medical Imaging Reagents Market, by Application 6.1 Overview 6.1.1 Global Medical Imaging Reagents Market Revenue, by Application, 2011 – 2019 (USD Million) 6.2 Diagnostics 6.2.1 Global Diagnostics Market Revenue, 2011 – 2019 (USD Million) 6.3 Drug Discovery and Development 6.3.1 Global Drug Discovery and Development Market Revenue, 2011 – 2019 (USD Million) 6.4 Research and Development 6.4.1 Global Research and Development Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Global Medical Imaging Reagents Market, by Geography 7.1 Overview 7.1.1 Global Medical Imaging Reagents Market Revenue, by Geography, 2011 – 2019 (USD Million) 7.2 North America 7.2.1 North America Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million) 7.3 Europe 7.3.1 Europe Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million) 7.4 Asia Pacific 7.4.1 Asia-Pacific Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
7
Defibrillators Market
7.5 Rest of the World (RoW) 7.5.1 RoW Medical Imaging Reagents Market Revenue, 2011 – 2019 (USD Million)
Chapter 8 Recommendations 8.1 Market Strategy for Success 8.2 Barriers to be Considered
Chapter 9 Company Profiles 9.1 Bayer Healthcare AG 9.1.1 Company Overview 9.1.2 Financial Overview 9.1.3 Product Portfolio 9.1.4 Business Strategies 9.1.5 Recent Developments 9.2 Beckman Coulter, Inc. 9.2.1 Company Overview 9.2.2 Financial Overview 9.2.3 Product Portfolio 9.2.4 Business Strategies 9.2.5 Recent Developments 9.3 Becton Dickinson & Company 9.3.1 Company Overview
Transparency Market Research
8
Defibrillators Market
9.3.2 Financial Overview 9.3.3 Product Portfolio 9.3.4 Business Strategies 9.4 Bracco Imaging SpA 9.4.1 Company Overview 9.4.2 Financial Overview 9.4.3 Product Portfolio 9.4.4 Business Strategies 9.4.5 Recent Developments 9.5 Cardinal Health, Inc. 9.5.1 Company Overview 9.5.2 Financial Overview 9.5.3 Product Portfolio 9.5.4 Business Strategies 9.5.5 Recent Developments 9.6 Lantheus Medical Imaging, Inc. 9.6.1 Company Overview 9.6.2 Financial Overview 9.6.3 Product Portfolio 9.6.4 Business Strategies 9.6.5 Recent Developments 9.7 Mallinckrodt Pharmaceuticals
Transparency Market Research
9
Defibrillators Market
9.7.1 Company Overview 9.7.2 Financial Overview 9.7.3 Product Portfolio 9.7.4 Business Strategies 9.7.5 Recent Developments
Browse the full Medical Imaging Reagents Market Report at http://www.transparencymarketresearch.com/biologic-imaging-reagents-market.html
9.8 Promega Corporation 9.8.1 Company Overview 9.8.2 Financial Overview 9.8.3 Product Portfolio 9.8.4 Business Strategies 9.8.5 Recent Developments 9.9 Siemens Healthcare 9.9.1 Company Overview 9.9.2 Financial Overview 9.9.3 Product Portfolio 9.9.4 Business Strategies 9.9.5 Recent Developments 9.10 Thermo Fisher Scientific, Inc.
Transparency Market Research
10
Defibrillators Market
9.10.1 Company Overview 9.10.2 Financial Overview 9.10.3 Product Portfolio 9.10.4 Business Strategies 9.10.5 Recent Developments
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Blog: http://tmrresearch.wordpress.com
Transparency Market Research
11